The central drug regulator has given its go-ahead to a proposal by the Indian Council of Medical Research for the clinical trial of convalescent plasma in COVID-19 patients, as per the protocol developed by ICMR.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/34PfRsq
via IFTTT
0 comments:
Post a Comment